Navigating Neuropsychology-logo

Navigating Neuropsychology

Podcasts >

More Information


United States






30| The NIH Toolbox – With Dr. Julie Hook

There is a benefit to developing computerized test batteries that can be used across large, longitudinal epidemiologic studies and prevention/intervention trials to facilitate comparison and harmonization across studies. The National Institute of Health (NIH) Toolbox is a royalty-free battery of tests designed to measure cognitive, sensory, motor, and emotional functioning that can be used across the lifespan and leverages Item Response Theory (IRT). Over 250 researchers from 80 institutions...


29| The Art and Science of Delivering Feedback – With Dr. Karen Postal (Part 2)

Karen Postal, Ph.D., ABPP-CN, talked to us about neuropsychological feedback in episode 17 ( Today, she graciously returns to continue the discussion of how to best deliver feedback and talk about her new book, Testimony That Sticks: The Art of Communicating Psychology and Neuropsychology to Juries. We also spend time talking to Karen about her training and supervision style, as well as her perspective on professional development based on her experience as American...


28| Board Certification Through ABPP/ABCN – With Dr. Kira Armstrong

Although board certification is not currently required in the field of neuropsychology, the number of board-certified neuropsychologists is rapidly increasing, suggesting that this may become the standard in the near future. This is relevant for both professionals and trainees because some employers are already beginning to require board certification. In this episode, we speak to Kira Armstrong, Ph.D., ABPP-CN about the process of becoming board certified, preparation strategies, and how...


27| Pediatric Traumatic Brain Injury – With Dr. Keith Yeates

We discussed INS leadership and research productivity with Keith Yeates, Ph.D., ABPP-CN, in episode 16. As the most published investigator of pediatric traumatic brain injury (TBI) in the world over the last 10 years, he returns today to discuss the prevalence rates and causes, behavioral sequalae, differences in outcomes, and psychosocial interventions for children with TBI. We also discuss symptom rating scales and performance validity tests in the assessment and management of children...


26| Neuropsych Essentials: Commentary on Clinical Report Writing

Last episode we spoke to Jacobus Donders, Ph.D., ABPP (CN, RP) about neuropsychological report writing (visit Today we provide commentary on that episode. Specifically, we discuss the Postal et al., 2018 “Stakeholders” paper from The Clinical Neuropsychologist as well as takeaways from our conversation with Dr. Donders. We also review other helpful tips to reduce report length and clinical time spent writing, which could free us up to devote more time for patient...


25| Neuropsych Essentials: Enhancing the Quality and Efficiency of Our Clinical Reports – With Dr. Jacobus Donders

Writing effective reports allows neuropsychologists to share important insights and recommendations gleaned from a neuropsychological evaluation. Although the format and length of reports may differ depending on the referral source and practice setting, there are common elements in every neuropsychological report. In this episode, we speak to Jacobus Donders, Ph.D., ABPP (CN, RP), about these common elements and how to increase the effectiveness of our written communication. Show notes...


24| Professional Development: Leadership, Training, and Supervision - With Dr. Neil Pliskin

We discussed the cognitive and emotional effects of electrical injury with Neil Pliskin, Ph.D., ABPP-CN, in Episode 9. As the former President of the Society of Clinical Psychology (SCN), a Program Director, and a clinical supervisor, he returns today to discuss professional development, the Houston Conference Guidelines, and effective supervision. We also provide our own commentary to delve into the details of these important topics. Show notes are available at...


23| Pediatric Epilepsy – With Dr. Nancy Nussbaum (Part 2)

Today we bring you the conclusion of our conversation with epilepsy expert Nancy Nussbaum, Ph.D., ABPP-CN (listen to Part 1 here: We cover a range of topics including the role of a clinical neuropsychologist on an interdisciplinary team, common academic challenges, various treatment options, providing psychoeducation for families, and much more. We also ask Nancy about her experience as President of the American Board of Clinical Neuropsychology (ABCN) and advice...


22| Pediatric Epilepsy – With Dr. Nancy Nussbaum (Part 1)

Epilepsy is a broad term used to describe various neurologic conditions that cause seizures. According to the Centers for Disease Control and Prevention (CDC), the U.S. had approximately 3 million adults and 470,000 children with epilepsy in 2015. Children with epilepsy are more likely to report academic difficulties, experience cognitive impairment, and live in poverty. Today we bring you Part 1 of our conversation with epilepsy expert Dr. Nancy Nussbaum, a board-certified neuropsychologist...


21| Cultural Neuropsychology: Embracing the Mosaic – With Dr. Monica Rivera Mindt

Clinical neuropsychologists are currently using instruments that are derived predominantly from monolingual, monocultural, and homogenous populations. According to U.S. Census projections, the U.S. is expected to continue becoming a more racially and ethnically pluralistic melting pot. As the number of White Americans is expected to decrease, the Hispanic population is projected to nearly double over the next few decades. The need for cultural responsiveness will only increase as the...


20| The Interplay Between Cerebrovascular Disease and Alzheimer’s Disease – With Dr. Adam Brickman

Adam Brickman, Ph.D., returns to discuss the involvement of white matter disease in Alzheimer’s disease progression and clinical presentation. Dr. Brickman discusses his research on the presence of biomarkers of cerebrovascular disease (e.g., white matter hyperintensities), which are present in aging and Alzheimer’s disease. Although cerebrovascular disease is traditionally associated with its own unique cognitive profile, Dr. Brickman discusses evidence suggesting that the cognitive...


19| Redefining Alzheimer's Disease: Does Cognition Matter? - With Dr. Adam Brickman

Despite global efforts to understand and ultimately assess, diagnose, and treat Alzheimer's disease (AD) more effectively, a consensus definition of AD still does not exist. In 2018, the National Institute of Aging – Alzheimer’s Association (NIA-AA) Research Framework recommended that we should shift the definition of AD from a syndrome (i.e., the cognitive/behavioral symptoms that individuals present with) to a purely biological construct, specifically the presence of βamyloid deposition,...


18| Fetal Alcohol Spectrum Disorder – With Dr. Jeffrey Wozniak

Today we give an overview of Fetal Alcohol Spectrum Disorder (FASD), which includes a collection of disorders that occur when a fetus is exposed to alcohol. We discuss this topic with Dr. Jeffrey Wozniak, a neuropsychologist with extensive research and clinical experience in FASD, and cover the physical, cognitive/developmental, and behavioral effects commonly seen in children and adults with this condition. Show notes are available at _________________ If you’d like...


17| The Art and Science of Delivering Feedback – With Dr. Karen Postal

Effective communication of neuropsychological test results and recommendations is a nuanced practice that is considered both a science and an art. Today we bring you our conversation with Karen Postal, Ph.D., ABPP-CN, the past president of the American Academy of Clinical Neuropsychology and the lead author of the book Feedback that Sticks: The Art of Effectively Communicating Neuropsychological Assessment Results. We talk with Dr. Postal about how to provide effective feedback as a...


16| Professional Development: INS Leadership and Research Productivity – With Dr. Keith Yeates

Today we discuss a wide variety of topics related to leadership, professional development, and research productivity with Keith Yeates, Ph.D., ABPP-CN, the sitting International Neuropsychological Society (INS) president at his 2019 presidential meeting in NYC. Show notes are available at _________________ If you’d like to support the show, here are a few easy ways: 1) Tell your friends and colleagues about it 2) Subscribe (free) and leave an iTunes review:...


15| Interventional Neuropsychology: Compensatory Cognitive Training - With Dr. Beth Twamley

Compensatory Cognitive Training (CCT) is a growing area of research and clinical practice for neuropsychologists in academic and rehabilitation settings. CCT leverages intact brain networks in order to teach skills that can improve someone’s ability to function independently in day-to-day life, despite the presence of other disrupted brain networks. CCT has wide-reaching applications and can be beneficial for many of the clinical populations neuropsychologists already work with, including...


14| Neuropsychology for Non-Neuropsychologists (Part 2)

We provided an overview of the field of neuropsychology in Episode 2, but we wanted to run it by someone outside the field to see if anything was unclear or if other questions came up. This episode is a Q & A with someone without any background in neuropsychology. We discuss lots of topics, such as the difference between normal and "abnormal" forgetfulness, why some people are able to process information quicker than others, the difference between dementia and Alzheimer's disease, and much...


13| Disclosing Alzheimer’s Disease Genetic Risk – With Dr. Meghan Collier

Clinical trials in Alzheimer’s disease frequently include the measurement of risk genes (i.e., the APOE e4 allele), and advancements in direct-to-consumer genetic testing (e.g., 23andMe) have made these biological data widely available to the public. Is it helpful or harmful for clinicians to disclose information on genetic risk for Alzheimer’s disease to patients and research participants? How can we explain concepts such as risk and incomplete penetrance to our patients? We pose these...


12| Inside NavNeuro: University of Florida ANST Q & A

We have a different kind of episode for you today. We were recently asked to speak about NavNeuro at an ANST brown bag lunch at the University of Florida. This episode is the audio from our Q & A with students who are particularly interested in the podcast and wanted to know more of the details about how we got started and what our plans are for the podcast, as well as a bit more about us on a personal level. We also cover lots of other interesting topics, like how to educate the general...


11| The Human Microbiome and Mental Illness: The Gut-Brain Axis - With Dr. Tanya Nguyen

In our bodies, microbial genes outnumber human genes by about 100 to 1. The human microbiome (the bacteria, fungi, and viruses that live in us) has been linked to gastrointestinal diseases, immune functioning, type 2 diabetes, obesity, and more recently cognitive and psychiatric functioning. Today we speak with Dr. Tanya Nguyen, a neuropsychologist whose research is helping to clarify this link. Show notes are available at _________________ If you’d like to support...